A citation-based method for searching scientific literature

Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand, Timothy G Lesnick, Vernon S Pankratz, Michael C Donohue, John Q Trojanowski. Lancet Neurol 2013
Times Cited: 2493







List of co-cited articles
528 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
28

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
17

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
13


The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
10


Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
Gill Livingston, Jonathan Huntley, Andrew Sommerlad, David Ames, Clive Ballard, Sube Banerjee, Carol Brayne, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper,[...]. Lancet 2020
9


The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
8


Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
7


Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E H Corder, A M Saunders, W J Strittmatter, D E Schmechel, P C Gaskell, G W Small, A D Roses, J L Haines, M A Pericak-Vance. Science 1993
6

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
6

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
Rahul S Desikan, Florent Ségonne, Bruce Fischl, Brian T Quinn, Bradford C Dickerson, Deborah Blacker, Randy L Buckner, Anders M Dale, R Paul Maguire, Bradley T Hyman,[...]. Neuroimage 2006
6



Biomarker modeling of Alzheimer's disease.
Clifford R Jack, David M Holtzman. Neuron 2013
560
5

Dementia prevention, intervention, and care.
Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, Sergi G Costafreda, Jonathan Huntley, David Ames, Clive Ballard, Sube Banerjee, Alistair Burns, Jiska Cohen-Mansfield,[...]. Lancet 2017
5

FreeSurfer.
Bruce Fischl. Neuroimage 2012
5

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Clifford R Jack, Marilyn S Albert, David S Knopman, Guy M McKhann, Reisa A Sperling, Maria C Carrillo, Bill Thies, Creighton H Phelps. Alzheimers Dement 2011
5

Amyloid beta: structure, biology and structure-based therapeutic development.
Guo-Fang Chen, Ting-Hai Xu, Yan Yan, Yu-Ren Zhou, Yi Jiang, Karsten Melcher, H Eric Xu. Acta Pharmacol Sin 2017
597
5

The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
5



Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
4

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
Michael C Donohue, Reisa A Sperling, David P Salmon, Dorene M Rentz, Rema Raman, Ronald G Thomas, Michael Weiner, Paul S Aisen. JAMA Neurol 2014
398
4

Automatically parcellating the human cerebral cortex.
Bruce Fischl, André van der Kouwe, Christophe Destrieux, Eric Halgren, Florent Ségonne, David H Salat, Evelina Busa, Larry J Seidman, Jill Goldstein, David Kennedy,[...]. Cereb Cortex 2004
4

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.
Ian G McKeith, Bradley F Boeve, Dennis W Dickson, Glenda Halliday, John-Paul Taylor, Daniel Weintraub, Dag Aarsland, James Galvin, Johannes Attems, Clive G Ballard,[...]. Neurology 2017
4

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.
Bruce Fischl, David H Salat, Evelina Busa, Marilyn Albert, Megan Dieterich, Christian Haselgrove, Andre van der Kouwe, Ron Killiany, David Kennedy, Shuna Klaveness,[...]. Neuron 2002
4

Defeating Alzheimer's disease and other dementias: a priority for European science and society.
Bengt Winblad, Philippe Amouyel, Sandrine Andrieu, Clive Ballard, Carol Brayne, Henry Brodaty, Angel Cedazo-Minguez, Bruno Dubois, David Edvardsson, Howard Feldman,[...]. Lancet Neurol 2016
868
4

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Bob Olsson, Ronald Lautner, Ulf Andreasson, Annika Öhrfelt, Erik Portelius, Maria Bjerke, Mikko Hölttä, Christoffer Rosén, Caroline Olsson, Gabrielle Strobel,[...]. Lancet Neurol 2016
4

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.
Chia-Chen Liu, Chia-Chan Liu, Takahisa Kanekiyo, Huaxi Xu, Guojun Bu. Nat Rev Neurol 2013
4

Sex differences in Alzheimer disease - the gateway to precision medicine.
Maria Teresa Ferretti, Maria Florencia Iulita, Enrica Cavedo, Patrizia Andrea Chiesa, Annemarie Schumacher Dimech, Antonella Santuccione Chadha, Francesca Baracchi, Hélène Girouard, Sabina Misoch, Ezio Giacobini,[...]. Nat Rev Neurol 2018
319
4

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
N Tzourio-Mazoyer, B Landeau, D Papathanassiou, F Crivello, O Etard, N Delcroix, B Mazoyer, M Joliot. Neuroimage 2002
4

High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Akinori Nakamura, Naoki Kaneko, Victor L Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe,[...]. Nature 2018
754
4

The evolution of preclinical Alzheimer's disease: implications for prevention trials.
Reisa Sperling, Elizabeth Mormino, Keith Johnson. Neuron 2014
434
4

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
Bradford C Dickerson, Akram Bakkour, David H Salat, Eric Feczko, Jenni Pacheco, Douglas N Greve, Fran Grodstein, Christopher I Wright, Deborah Blacker, H Diana Rosas,[...]. Cereb Cortex 2009
674
4

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
Peter T Nelson, Irina Alafuzoff, Eileen H Bigio, Constantin Bouras, Heiko Braak, Nigel J Cairns, Rudolph J Castellani, Barbara J Crain, Peter Davies, Kelly Del Tredici,[...]. J Neuropathol Exp Neurol 2012
4

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Bruno Dubois, Harald Hampel, Howard H Feldman, Philip Scheltens, Paul Aisen, Sandrine Andrieu, Hovagim Bakardjian, Habib Benali, Lars Bertram, Kaj Blennow,[...]. Alzheimers Dement 2016
883
4

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
Sebastian Palmqvist, Philip S Insel, Erik Stomrud, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Udo Eichenlaub, Jeffrey L Dage, Xiyun Chai, Kaj Blennow,[...]. EMBO Mol Med 2019
139
4

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Brian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, Joshua C Bis, Vincent Damotte, Adam C Naj, Anne Boland, Maria Vronskaya, Sven J van der Lee, Alexandre Amlie-Wolf,[...]. Nat Genet 2019
4

Blood-brain barrier breakdown in the aging human hippocampus.
Axel Montagne, Samuel R Barnes, Melanie D Sweeney, Matthew R Halliday, Abhay P Sagare, Zhen Zhao, Arthur W Toga, Russell E Jacobs, Collin Y Liu, Lilyana Amezcua,[...]. Neuron 2015
4

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.
John C Morris, Catherine M Roe, Chengjie Xiong, Anne M Fagan, Alison M Goate, David M Holtzman, Mark A Mintun. Ann Neurol 2010
635
4

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
Leslie M Shaw, Hugo Vanderstichele, Malgorzata Knapik-Czajka, Christopher M Clark, Paul S Aisen, Ronald C Petersen, Kaj Blennow, Holly Soares, Adam Simon, Piotr Lewczuk,[...]. Ann Neurol 2009
4

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman,[...]. Lancet Neurol 2014
4

Cognitive reserve.
Yaakov Stern. Neuropsychologia 2009
4

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
4

Plasma β-amyloid in Alzheimer's disease and vascular disease.
Shorena Janelidze, Erik Stomrud, Sebastian Palmqvist, Henrik Zetterberg, Danielle van Westen, Andreas Jeromin, Linan Song, David Hanlon, Cristina A Tan Hehir, David Baker,[...]. Sci Rep 2016
316
4

Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.
Ellen Grober, Charles B Hall, Richard B Lipton, Alan B Zonderman, Susan M Resnick, Claudia Kawas. J Int Neuropsychol Soc 2008
281
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.